It is well-established that the use of the anti-cancer drug CP is associated with several adverse effects, especially nephrotoxicity and vascular injury, and hence it is widely used experimentally in rats to induce kidney, cardiac and vascular injury [12,13,14,17,20]. Here, CP is linked to cancer.